In this video interview, Marc Buyse, ScD, founder and CEO of IDDI, examines the most common threats to trial data reliability ...
A new analysis represents the largest effort yet to systematically parse all the data from high-quality clinical trials on cannabis and mental health. The evidence is lacking.
Using medical or recreational marijuana to ease symptoms of numerous mental health conditions doesn’t work, according to new ...
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical ...
Should A1c remain the gold standard for routine monitoring of glucose control in people with diabetes, or is it time to shift ...
MedPage Today on MSN
Tranexamic Acid Reduces Major Bleeding in Urologic Surgery
Prior results with the drug in other surgical settings have been mixed ...
Contrary to existing evidence from observational studies, the meningococcal B vaccine (4CMenB) has no effect on preventing ...
Could hyperbaric oxygen treat PTSD, depression, and anxiety? New evidence suggests that this treatment may rewire the ...
Annualized height velocity of 9.05 cm/year (LS mean) for TransCon hGH-treated children was similar at Week 52 to daily somatropin-treated ...
Aspen Neuroscience’s stem cell therapy improved Parkinson’s disease symptoms for all eight treated patients after one year, ...
Researchers examined 54 clinical trials to see if cannabis helps treat mental health or addiction issues. They found minimal proof of benefit, alongside a higher risk of mild side effects like ...
FDA granted a narrow indication for CFD-FOLR1, targeting impaired folate transport into the CNS that drives developmental delay, seizures, movement disorders, and autistic features in some patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results